Effects of cytostatics on the selected parameters of cell-mediated immunity in dogs

• Autorzy: Brodzki P. , Wrona Z. , Piech T. , Brodzki A.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to assess the effects of tamoxifen and cyclophosphamide on the selected cell-mediated immunity parameters in dogs. The study included 18 dogs aged 5-10 years. The experimental group consisted of 12 animals with neoplastic lesions classified as the first or second staging group (according to the WHO TMN classification). This group was divided into two subgroups: I - six dogs receiving oral tamoxifen, and II - six dogs with cyclophosphamide administered orally. The control group included six healthy dogs. The blood was sampled from the saphenous access vein two times at 14-d intervals before the drug administration, three times every 7 d during administration, and two times every 14 d after completion of the therapy. The basic blood tests were carried out and the subpopulations of TCD4+ and TCD8+ lymphocytes, and phagocytic activity of granulocytes and monocytes were determined using flow cytometry. It was found that tamoxifen induced a marked increase in WBC and neutrophil counts, increased phagocytic activity of monocytes, and changed the CD4+:CD8+ ratio (in favour of cytotoxic lymphocyte subpopulation). These findings indicated the stimulation of cell-mediated immunity mechanisms. Cyclophosphamide caused a substantial decrease in the overall leukocyte pool and reduced the percentage of cells activated for phagocytosis, both neutrophils and monocytes even after completion of its administration, which proves its immunosuppressive effects.

Słowa kluczowe

EN

basic parameter; cell-mediated response; cellular immunity; cyclophosphamide; cytostatics; dog; tamoxifen; animal organism

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2011
• Tom: 55
• Numer: 1
• Opis fizyczny: p.87-93,ref.

Twórcy

autor

Brodzki P.

• Department of Andrology and Biotechnology of Animal Reproduction, Faculty of Veterinary Medicine, University of Natural Sciences in Lublin, 20-612 Lublin, Poland

autor

Wrona Z.

autor

Piech T.

autor

Brodzki A.

Bibliografia

• 1. Beckman M.W., Mohrmann T., Nideracher D.: Wirkungsmechanizmen von steroidhormonen und steroidhormonantagonisten und ihre Bedeutung für die tumorkarcinogenese. Der Gynekologie 1997, 30, 617- 623.
• 2. Bowen R. H., Olson P.N., Young S., Wihrow S.J.: Efficacy and toxicity of tamoxifen citrate for prevention and termination of pregnancy in bitches. Am J Res 1998. 49, 27-31.
• 3. Brodzki P., Wrona Z., Krakowski L., Brodzki A.: Influence of tamoxifen on sexual impulse and semen biological values in male dogs. Bull Vet Inst Pulawy 2007, 53, 383-393.
• 4. Chenoweth P.H., Chase C.C., Risko C.A., Larsen R.E.: Characterization of gossypol - induced sperm abnormalites in bulls. Theriogenology 2000, 53, 1193-1203.
• 5. Coletta A.A., Benson J.R., Baum M.: Alternative mechanism of action of anti-oestrogens. Brest Cancer Res 1994, 40, 228-234.
• 6. Doshi M.B., Derashri H.J., Mehta V.M., Kodagali S.B.: Effects of clomifene on blood testosterone and quality of ejaculates in buffalo bulls. Indian Vet J 1994, 71, 246- 249.
• 7. Dzierżanowska D., Pawińska A.: Infection during chemotherapy of tumors. Nowa Medycyna 1998, 5, 46-48.
• 8. Grądzki Z.: Some aspects of immunosuppressive action of chemotherapeutics on immunological reactions. Medycyna Wet 1993, 49, 198-202.
• 9. Iwasaki K., Toms S.A., Barnett G.H., Es M.L., Gupta M.K., Barna B.P.: Inhibitory effects of tamoxifen and tumor necrosis factor a on human glioblastoma cells. Cancer Immunol Immunother 1995, 40, 228-234.
• 10. Kampen C., Mallard B.A., Wilkie B.N.: Adhesion molecules and lymphocyte subsets in milk and blood of periparturient Holstein cows. Vet Immunol Immunopathol 1999, 69, 23-32.
• 11. Kłaczyński W.: Effectiveness of tamoxifen - hexal in the treatment of neoplasms in dogs. Medycyna Wet 1998, 54, 281-283.
• 12. Komi J., Lassila O.: Nonsteroidal anti - estrogens inhibit the functional differentiation of human monocyte - derived dendritic cells. Blood 2000, 95, 2875-2882.
• 13. Kostro K.: Stimulation of nonspecific immunity in female polar foxes in the second part of pregnancy and heath state of their progeny. Ann Univ Mariae-Curie Skłodowska [Vet] 2006, 26, 219-228.
• 14. Krakowski L., Krzyżanowski J., Wrona Z.: The creating of cellular and humoral nonspecific defences in heifers during the estrus cycle. Ann Univ Mariae-Curie Skłodowska [Vet] 1998, 53, 217-221.
• 15. LeBlanc G.A., Waxman D.J.: Mechanism of cyclophosphamide action on hepatic P-450 expression. Cancer Res 1990, 50, 5720- 5726.
• 16. Markowska J.: Chemotherapy of tumors of parturition organ. Nowa Medycyna 1998, 5, 28-31.
• 17. Motoyoshi Y., Kaminoda K., Saitoho., Hamasaki K., Nakao K., Ishii N., Nagayama Y., Eguclii K.: Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncol Rep 2006, 16, 141-146.
• 18. Nielsen H., Rorth M.: Phagocytosis and killing of Candida albicans by blood monocytes from patients with non-seminomatous testicular carcinoma: effect of chemotherapy. Acta Pathol Microbiol Immunol Scand 1985, 93, 85-89.
• 19. Nielsen H., Rorth M., Bennedsen J.: Monocyte chemotaxis in patients with non-seminomatous testicular carcinoma. Effect of chemotherapy. Cancer Immunol Immunother 1985, 19, 68-71.
• 20. Obmińska-Domaradzka B., Świtała M., Dębowy J., Kiczka W., Garbuliński T.: Effects oflisozyme dimer of humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunosuppressed mice. J Vet Med B 1997, 44, 591-598.
• 21. Penny I.A., Amstrong., Bramley T.A., Collins R.A., Watson E.D.: Immune cells and cytokine production in the bovine corpus luteum throughont the oestrus cycle and after induced luteolysis. J Reprod Fert 1999, 115, 87-96.
• 22. Siwicki A.K.: The role of immunology in neoplastic diseases. 1st Scientific Conference: Veterinary Oncology. Olsztyn, Poland, 1997.
• 23. Subandrio A.L., Sheldon I.M., Noakes D.E.: Peripherial and intrauterine neutrophil function in cow: The influence of endogenous and exogenous sex steroid hormones. Theriogenology 2000, 53, 1591-1608.
• 24. Sulikowska M., Skrzydlewska E., Sobaniec-Łotowska M., Famulski W., Terlikowski S., Kańczuga-Koda L., Reszeć J., Daniszewska I.: Effect of cyclophosphamide- induced generation reactive oxygen forms on ultrastructure of the liver and lung. Bull Vet Inst Pulawy 2002, 46, 239-246.
• 25. Waddle J.R., Fine R.L., Case B.C., Trogdon M.L., Tyczkowska K., Frazier D., Page R.L.: Phase 1 of pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs. Cancer Chemother Pharmacol 1999, 44, 74-80.
• 26. Wrona Z., Krakowski L., Łopuszyński W., Kostro K., Kowalski C., Brodzki P.: Evaluation of fertility and nonspecific cellular defence in male dogs after applying tamoxifen. Medycyna Wet 2003, 59, 1000-1004.